Skip to main content
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Clinical Diabetes
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes Spectrum

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
  • More from ADA
    • Diabetes
    • Diabetes Care
    • Clinical Diabetes
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, abridged
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes Spectrum
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Browse
    • Issue Archive
    • Saved Searches
    • COVID-19 Article Collection
    • ADA Standards of Medical Care
    • ADA Standards of Medical Care, Abridged
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Journal Policies
    • Instructions for Authors
Departments

Diabetes Spectrum: Past, Present, and Future

  1. Joshua J. Neumiller, Editor-in-Chief
  1. Department of Pharmacotherapy, College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA
  1. Corresponding author: Joshua J. Neumiller, jneumiller{at}wsu.edu
Diabetes Spectrum 2018 Nov; 31(4): 297-298. https://doi.org/10.2337/ds18-0051
PreviousNext
  • Article
  • Info & Metrics
  • PDF
Loading

In this, my last issue as editor-in-chief of Diabetes Spectrum, I wanted to take a moment to reflect on the past 5 years and convey my thanks to the American Diabetes Association (ADA) and the many individuals I have had the privilege of interacting with during my tenure. Serving as editor for the journal has been among the most rewarding professional experiences I have engaged in thus far in my career. After I was introduced to former editor-in-chief Jackie Boucher by my mentor, the late R. Keith Campbell, in 2009, Jackie was kind enough to invite me to serve on the Diabetes Spectrum editorial board. After serving in various roles with the journal thereafter, I was fortunate enough to eventually succeed Jackie as editor in 2014. Through this role, I have had the opportunity to network with and learn from a multitude of brilliant clinicians and educators, each of whom I want to thank for an amazing experience.

I was just looking back through the issues of Diabetes Spectrum published since 2014. The first issue produced in my editorial term was particularly meaningful to me. The guest editor for that issue’s From Research to Practice Section, titled “Pharmacotherapy of Diabetes: Past, Present, and Future” (1), was none other than my mentor who had helped to usher me onto the journal’s editorial board: R. Keith Campbell. Keith, who, sadly, passed away in late 2017, was a wonderful friend with a true passion for providing excellent diabetes care and mentoring young professionals in the field. He had graciously accepted our invitation to serve as guest editor for my inaugural issue as editor-in-chief.

Together with Curtis L. Triplitt, PharmD, CDE (the associate editor who coordinated that research section), Keith convened an impressive group of invited experts as contributing authors. I remember vividly that Curtis, although fresh on the job as an associate editor, was eager to jump in and take a leadership role with Keith to pull the issue together. I was extraordinarily proud of the product our team was able to produce for our first issue under Keith’s and Curtis’ leadership.

Although the end of my term as editor is bittersweet, I am so very excited that Curtis will be assuming this role for the journal beginning with the first issue of 2019. Given Curtis’ excellence, as demonstrated not only in the production of that first research section of my tenure, but also in his active role in every issue since then, Diabetes Spectrum undoubtedly will be in great hands under his leadership.

During my tenure, I have been fortunate to work with an outstanding group of associate editors and ADA staff members, who have all made the experience both enjoyable and rewarding. Although space limitations prohibit me from naming every contributor to the 20 issues published in the past 5 years, I do want to take a moment to thank a few individuals by name. First, I want to thank Joan Garrett, Keang Hok, Christian Kohler, Shannon Potts, and Lyn Reynolds at ADA for their tireless work for and support of the entire editorial team.

I would also like to thank the amazing associate editors I have had the privilege of working with, including, in addition to Curtis, Sandra Drozdz Burke, Fran R. Cogen, Andrea Vegh Dunn, Janine Freeman, Laura B. Hieronymus, Carol J. Homko, Alan J. Kelly, Lindy Swain, and Jeffrey J. VanWormer. These individuals have done an outstanding job shepherding articles through the peer review process, coordinating research sections, and contributing in countless other ways to our efforts to produce the excellent content published within each issue of the journal.

Next, I would like to thank all of the individuals who have provided exceptional service as members of the editorial board and the excellent guest editors who volunteered their time, energy, and expertise to produce a series of clinically useful and educational From Research to Practice sections during my tenure.

Finally, I want to give a huge thanks to my friend and colleague Debbie Kendall, managing editor of Diabetes Spectrum. Debbie, who has served as managing editor since the journal’s sixth volume year in 1993, is a true pillar of the editorial team. Her institutional knowledge and work ethic are essential to the successful production of each and every Diabetes Spectrum issue.

In conclusion, it has been my absolute pleasure to serve as editor-in-chief of Diabetes Spectrum. As a continuing member of the journal’s readership, I look forward to the informative issues that Curtis and his team of associate editors have in store for us starting in 2019.

Duality of Interest

No potential conflicts of interest relevant to this article were reported.

  • © 2018 by the American Diabetes Association.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0 for details.

Reference

  1. 1.↵
    1. Campbell RK
    (Ed.). From Research to Practice: Pharmacotherapy of diabetes: past, present, and future. Diabetes Spectrum 2014;27:79–112
    OpenUrl
View Abstract
PreviousNext
Back to top
Diabetes Spectrum: 31 (4)

In this Issue

November 2018, 31(4)
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Masthead (PDF)
Sign up to receive current issue alerts
View Selected Citations (0)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes Spectrum.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Diabetes Spectrum: Past, Present, and Future
(Your Name) has forwarded a page to you from Diabetes Spectrum
(Your Name) thought you would like to see this page from the Diabetes Spectrum web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Diabetes Spectrum: Past, Present, and Future
Joshua J. Neumiller
Diabetes Spectrum Nov 2018, 31 (4) 297-298; DOI: 10.2337/ds18-0051

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

Diabetes Spectrum: Past, Present, and Future
Joshua J. Neumiller
Diabetes Spectrum Nov 2018, 31 (4) 297-298; DOI: 10.2337/ds18-0051
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Duality of Interest
    • Reference
  • Info & Metrics
  • PDF

Related Articles

Cited By...

More in this TOC Section

Departments

  • Smart Connected Insulin Pens, Caps, and Attachments: A Review of the Future of Diabetes Technology
  • Brief Literature Review: The Potential of Diabetes Technology to Improve Sleep in Youth With Type 1 Diabetes and Their Parents: An Unanticipated Benefit of Hybrid Closed-Loop Insulin Delivery Systems
  • Finding My Diabetes Community
Show more Departments

Editorial

  • Finding My Diabetes Community
  • Oh, What Times We Live In!
Show more Editorial

Similar Articles

Navigate

  • Current Issue
  • Papers in Press
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes
  • Diabetes Care
  • Clinical Diabetes
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Spectrum Print ISSN: 1040-9165, Online ISSN: 1944-7353.